ArticlebioRxiv : the preprint server for biology2026
Uncertainty-aware synthetic lethality prediction with pretrained foundation models.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Synthetic lethality (SL) offers a promising paradigm for targeted cancer therapy, yet experimental identification of SL gene pairs remains costly, context-dependent, and biased toward well-studied genes. Existing computational approaches often rely on curated protein-protein interaction (PPI) networks and Gene Ontology (GO) annotations, which limit their ability to generalize to novel genes. Here we introduce Cilantro-sl, a two-stage, graph-free framework that leverages pretrained biological foundation models to predict SL pairs with calibrated uncertainty. In Stage 1, we apply a pretrained single-cell foundation model to bulk RNA-seq profiles of cancer cell lines to obtain context-aware embeddings and perform in silico gene knockouts to generate delta embeddings. These perturbation signals are further conditioned on a data-driven gene prior and supervised with CRISPR viability readouts to learn knockout-aware viability embeddings. In Stage 2, we derive pairwise features from these embeddings and train a lightweight classifier to distinguish SL from non-SL pairs. To enable reliable experimental prioritization, Cilantro-sl incorporates conformal prediction, producing calibrated and interpretable prediction sets that highlight high-confidence SL candidates. Across two evaluation settings, including zero-shot generalization to unseen gene pairs and to unseen genes, ablation analyses show that viability pretraining and the gene prior substantially improve performance while avoiding reliance on PPI and GO features. Cilantro-sl therefore transforms pretrained biological representations into practical, uncertainty-aware hypotheses that support robust and scalable discovery of therapeutic targets.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.